Literature DB >> 26265094

Visual Predictive Check in Models with Time-Varying Input Function.

Anna Largajolli1, Alessandra Bertoldo2, Marco Campioni3, Claudio Cobelli1.   

Abstract

The nonlinear mixed effects models are commonly used modeling techniques in the pharmaceutical research as they enable the characterization of the individual profiles together with the population to which the individuals belong. To ensure a correct use of them is fundamental to provide powerful diagnostic tools that are able to evaluate the predictive performance of the models. The visual predictive check (VPC) is a commonly used tool that helps the user to check by visual inspection if the model is able to reproduce the variability and the main trend of the observed data. However, the simulation from the model is not always trivial, for example, when using models with time-varying input function (IF). In this class of models, there is a potential mismatch between each set of simulated parameters and the associated individual IF which can cause an incorrect profile simulation. We introduce a refinement of the VPC by taking in consideration a correlation term (the Mahalanobis or normalized Euclidean distance) that helps the association of the correct IF with the individual set of simulated parameters. We investigate and compare its performance with the standard VPC in models of the glucose and insulin system applied on real and simulated data and in a simulated pharmacokinetic/pharmacodynamic (PK/PD) example. The newly proposed VPC performance appears to be better with respect to the standard VPC especially for the models with big variability in the IF where the probability of simulating incorrect profiles is higher.

Entities:  

Keywords:  mixed-effect modeling; model diagnostic; models using input function; visual predictive check

Mesh:

Substances:

Year:  2015        PMID: 26265094     DOI: 10.1208/s12248-015-9808-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  18 in total

1.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

Authors:  E Breda; M K Cavaghan; G Toffolo; K S Polonsky; C Cobelli
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

2.  The oral glucose minimal model: estimation of insulin sensitivity from a meal test.

Authors:  Chiara Dalla Man; Andrea Caumo; Claudio Cobelli
Journal:  IEEE Trans Biomed Eng       Date:  2002-05       Impact factor: 4.538

3.  Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.

Authors:  Karl Brendel; Emmanuelle Comets; Céline Laffont; Christian Laveille; France Mentré
Journal:  Pharm Res       Date:  2006-08-12       Impact factor: 4.200

Review 4.  Diagnosing model diagnostics.

Authors:  M O Karlsson; R M Savic
Journal:  Clin Pharmacol Ther       Date:  2007-07       Impact factor: 6.875

5.  Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.

Authors:  Radojka M Savic; Mats O Karlsson
Journal:  AAPS J       Date:  2009-08-01       Impact factor: 4.009

6.  Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Authors:  Martin Bergstrand; Andrew C Hooker; Johan E Wallin; Mats O Karlsson
Journal:  AAPS J       Date:  2011-02-08       Impact factor: 4.009

7.  Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion.

Authors:  G Toffolo; F De Grandi; C Cobelli
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

8.  Diabetes: Models, Signals, and Control.

Authors:  Claudio Cobelli; Chiara Dalla Man; Giovanni Sparacino; Lalo Magni; Giuseppe De Nicolao; Boris P Kovatchev
Journal:  IEEE Rev Biomed Eng       Date:  2009-01-01

9.  Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check.

Authors:  Y Yano; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-04       Impact factor: 2.745

10.  Extensions to the visual predictive check to facilitate model performance evaluation.

Authors:  Teun M Post; Jan I Freijer; Bart A Ploeger; Meindert Danhof
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-01-16       Impact factor: 2.745

View more
  2 in total

1.  Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive Dosing.

Authors:  Monica Simeoni; Chao Chen
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

2.  A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide.

Authors:  Lai San Tham; Kevin M Pantalone; Kathleen Dungan; Kashif Munir; Cheng Cai Tang; Manige Konig; Anita Y M Kwan
Journal:  Diabetes Obes Metab       Date:  2021-11-08       Impact factor: 6.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.